Hyunil Jo

Hyunil Jo

Auto-generated profile, based on publicly available information

Hyunil Jo

Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA 94158

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2015 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
NRNilgun I. Reed
Nilgun I. Reed
HJHyunil Jo
Hyunil Jo
CCChun Chen
Chun Chen
KTKazuyuki Tsujino
Kazuyuki Tsujino
TAThomas D. Arnold
Thomas D. Arnold
DSDean Sheppard
Dean Sheppard
An α v β 1 inhibitor attenuated pulmonary and liver fibrosis in mouse models.

11 October 2012 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
HJHyunil Jo
Hyunil Jo
NMNataline Meinhardt
Nataline Meinhardt
YWYibing Wu
Yibing Wu
SKSwapnil Kulkarni
Swapnil Kulkarni
XHXiaozhen Hu
Xiaozhen Hu
DGDoron C. Greenbaum
Doron C. Greenbaum

22 May 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MHMary Rose Hilaire
Mary Rose Hilaire
IAIsmail A. Ahmed
Ismail A. Ahmed
CLChun-Wei Lin
Chun-Wei Lin
HJHyunil Jo
Hyunil Jo
WDWilliam F. DeGrado
William F. DeGrado
FGFeng Gai
Feng Gai
Significance: Herein, we report a tryptophan-based fluorophore that emits in the visible spectral region when excited with 355-nm light. Because this blue fluorescent amino acid has a small size and affords unique photophysical properties, we expect that it will find use in various biological studies, especially in spectroscopic and/or microscopic measurements where an amino acid-sized fluorescence reporter is required.

23 September 2012 in Nature Chemistry
Verified
Journal Article
Open access
PDF file
ARAmanda J. Reig
Amanda J. Reig
MPMarcos M. Pires
Marcos M. Pires
RSRae Ana Snyder
Rae Ana Snyder
YWYibing Wu
Yibing Wu
HJHyunil Jo
Hyunil Jo
WDWilliam F. DeGrado
William F. DeGrado
De novo proteins provide a unique opportunity to investigate the structure–function relationships of metalloproteins in a minimal, well-defined and controlled scaffold. Here, we describe the rational programming of function in a de novo designed di-iron carboxylate protein from the Due Ferri family. Originally created to catalyse the O2-dependent, two-electron oxidation of hydroquinones, the protein was reprogrammed to catalyse the selective N-hydroxylation of arylamines by remodelling the substrate access cavity and introducing a critical third His ligand to the metal-binding cavity. Additional second- and third-shell modifications were required to stabilize the His ligand in the core of the protein. These structural changes resulted in at least a 106-fold increase in the relative rate between the arylamine N-hydroxylation and hydroquinone oxidation reactions. This result highlights the potential for using de novo proteins as scaffolds for future investigations of the geometric and electronic factors that influence the catalytic tuning of di-iron active sites.

21 April 2017 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
TWTuo Wang
Tuo Wang
HJHyunil Jo
Hyunil Jo
WDWilliam F. DeGrado
William F. DeGrado
MHMei Hong
Mei Hong

25 February 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JWJizhou Wang
Jizhou Wang
CMChunlong Ma
Chunlong Ma
JWJun Wang
Jun Wang
HJHyunil Jo
Hyunil Jo
BCBelgin Canturk
Belgin Canturk
WDWilliam F. DeGrado
William F. DeGrado